Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

PRIMARY OBJECTIVES:

Stage 1: To evaluate education quality of the intervention in Black or African American men with prostate cancer.

Stage 2: To evaluate feasibility of the TGT intervention among Black or African American men with prostate cancer

SECONDARY OBJECTIVES:

Stage 1:

1. To evaluate completeness of the intervention content. 2. To identify barriers and facilitators for using the intervention.

Stage 2:

1. To evaluate the acceptability of the intervention among Black or African American men with prostate cancer. 2. To evaluate change in participant knowledge about tumor genetic testing among Black or African American men with prostate cancer. 3. To evaluate change in patient attitudes toward tumor genetic testing among Black or African American men with prostate cancer. 4. To evaluate change in participant expectations of tumor genetic testing among Black or African American men with prostate cancer. 5. To evaluate patient perspectives on the intervention. 6. To evaluate the rate of TGT among Black or African American men with prostate cancer who have received the tumor genetic pre-test counseling tool.

OUTLINE:

This is a two-stage study. In Stage 1, Adult Black or African American men with metastatic prostate cancer who have not made a decision about TGT, or who have decided to undergo TGT, or patients who have decline TGT about tumor genetic testing will participate in development by answering questionnaires and utilizing the pilot application for up to 60 days. The investigators will then refine the tool to be piloted in Stage 2.

Stage 2: A pilot study of participants who are planning to have a discussion about undergoing tumor genetic testing with their oncology provider will be invited to join and utilize the tool, and answer questionnaires about the tool.

• Mean score of Acceptability of Intervention Measure (AIM) (Stage 2) [Срок оценки: Up to 60 days]
• Mean score of investigator-developed, measure of acceptability items (Stage 2) [Срок оценки: Up to 60 days]
• Mean score of cancer genomic testing knowledge (Stage 2) [Срок оценки: Up to 60 days]
• Proportion of participants who select correct response in each genomic testing knowledge instrument item (Stage 2) [Срок оценки: Up to 60 days]
• Proportion of participants who answer "Yes" to each attitude item in the Attitude and expectations for tumor genetic testing survey (Stage 2) [Срок оценки: Up to 60 days]
• Proportion of participants who answer "Strongly Agree" or "Agree" to the expectation item in the Attitude and expectations for tumor genetic testing survey (Stage 2) [Срок оценки: Up to 60 days]
• Participant-reported perspectives of intervention in a semi-structured interview. (Stage 2) [Срок оценки: Up to 60 days]
• Proportion of participants who have received the tumor genetic pre-test counseling tool who undergo TGT by chart review (Stage 2) [Срок оценки: Up to 90 days]